The Gross Margin of Nabriva Therapeutics PLC (NBRV) is 22.62%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2022-12-31 | 22.62% |
2021-12-31 | 54.50% |
2020-12-31 | 84.69% |
2019-12-31 | 99.26% |
2018-12-31 | -464.35% |
2017-12-31 | -296.82% |
2016-12-31 | 26.67% |